Aerosolized budesonide therapy in acute moderate exacerbations of Indian asthmatics

S. K. Agarwal (Varanasi, India)

Source: Annual Congress 2004 - Targeting acute and chronic airway obstruction
Session: Targeting acute and chronic airway obstruction
Session type: Thematic Poster Session
Number: 2159
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. K. Agarwal (Varanasi, India). Aerosolized budesonide therapy in acute moderate exacerbations of Indian asthmatics. Eur Respir J 2004; 24: Suppl. 48, 2159

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Utility of aerosolized budesonide therapy in acute moderate exacerbations of asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 283s
Year: 2003

Aerosolized fluticasone propionate therapy in acute moderate exacerbations of asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 45s
Year: 2002

The role of nebulised budesonide in the treatment of acute exacerbations of COPD
Source: Eur Respir J 2007; 30: 399-400
Year: 2007


Comparison of oral prednisolone and nebulized budesonide in the treatment of acute exacerbations of COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 214s
Year: 2001

Efficacy and safety of intravenous montelukast in patients with acute exacerbations of bronchial asthma
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma
Year: 2008


Clinical efficacy of nebulised budesonide in acute exacerbation of COPD
Source: Annual Congress 2010 - COPD: treatment and monitoring
Year: 2010

Nebulized therapy in bronchial asthma exacerbation
Source: Eur Respir J 2002; 20: Suppl. 38, 52s
Year: 2002

Utility of high dose inhaled fluticasone therapy for the early management of acute exacerbations of asthma
Source: Annual Congress 2009 - Next generation bronchodilators
Year: 2009


The role of nebulised budesonide in the treatment of exacerbations of COPD
Source: Eur Respir J 2007; 29: 660-667
Year: 2007



Montelukast and budesonide therapy of asthmatic patients suffering from chronic cough
Source: Eur Respir J 2006; 28: Suppl. 50, 440s
Year: 2006

Efficacy of budesonide inhalation suspension in acute exacerbation of bronchial asthma in adults
Source: Eur Respir J 2006; 28: Suppl. 50, 500s
Year: 2006

Inhaled corticosteroids in the treatment of acute asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 305s
Year: 2002

A comparision of inhaled budesonide and oral prednisolone for children with acute asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 134s
Year: 2003

Severe exacerbations, decline in lung function and inhaled budesonide in asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 619s
Year: 2007

Oral montelukast in patients with acute severe asthma
Source: Annual Congress 2007 - Recent advances in our understanding of the treatment of asthma
Year: 2007


Montelukast as add-on therapy in severe noninfectious COPD exacerbations
Source: Eur Respir J 2003; 22: Suppl. 45, 241s
Year: 2003

Oral corticosteroids in the treatment of exacerbation of severe asthma
Source: Virtual Congress 2020 – Exhaled biomarkers of asthma and the asthma burden
Year: 2020


Nebulizer therapy with budesonide in addition to systemic corticosteroids in acute severe asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 541s
Year: 2004

Efficacy of short-term high dose predonisolone therapy in acute exacerbation of bronchial asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 71s
Year: 2001

An economic evaluation of adding inhaled corticosteroids to systemic corticosteroids for treating acute asthma exacerbations
Source: International Congress 2019 – Severe acute asthma and troublesome wheezing
Year: 2019